Log in

Journal & Publications

  • Home
  • Journal & Publications

International Journal of Neuropsychopharmachology (IJNP)

The central focus of the International Journal of Neuropsychopharmacology (IJNP) is on research that advances understanding of existing and new neuropsychopharmacological agents including their mode of action and clinical application or provides insights into the biological basis of psychiatric disorders and thereby advances their pharmacological treatment.

IJNP has an Impact Factor of 3.981 and a 5-year Impact Factor of 4.377 according to the most recent Journal Citation Reports® (Thomson Reuters). This places the journal 42 out of 261 in the category of Pharmacology & Pharmacy. The Impact Factor is the average number of times articles from the journal published in the past two years have been cited in the JCR year. The Impact Factor is calculated by dividing the number of citations in the JCR year by the total number of articles published in the two previous years. The five-year Impact Factor is calculated in the same way as the standard Impact Factor, except the standard two-year window for inclusion of articles is extended to five years.

Current statistics about the Journal are shown in the infographic and illustrate the rapid speed of online publication from final acceptance of the article.

Professor Siegfried Kasper, current CINP president, stated, “IJNP has been an important part of the life of the CINP and a venue for the publication of outstanding and impactful science. Under the leadership of our editor-in-chief, Alan Frazer, our outstanding collaboration with Oxford University Press is helping us to increase the visibility of papers appearing in IJNP. It is also making IJNP more user-friendly for both contributing authors and readers.”

Bipolar Guidelines

A working group led by Dr. Konstantinos Fountoulakis developed the first International College of Neuropsychopharmacology (CINP) clinical guidelines for the treatment of Bipolar Disorders in adult patients. Their work is very thoroughly described in four separate papers (parts) included in this issue of the journal. The first article is Background and Methods of the Development of Guidelines (Fountoulakis et al., 2017d); part 2 is Review, Grading of the Evidence, and a Precise Algorithm (Fountoulakis et al., 2017c); part 3 is The Clinical Guidelines (Fountoulakis et al., 2017a); and Part 4 is Unmet Needs in the Treatment of Bipolar Disorder and Recommendations for Future Research (Fountoulakis et al., 2017b).
Click here to read more.

Schizophrenia Guidelines

The schizophrenia treatment algorithm for the CINP website produced by Stefan Leucht, Celso Arango, Shitij Kapur, Wolfgang Fleischhacker, Jim van Os, Scott Stroup and Christoph Correll is now available.

The structure is as follows: we have a number of recommendations which are broadly classified in “A) Treatment of an acute episode”, “B) Specific patient populations/symptoms”, “C) maintenance treatment” and “D) prophylaxis/management of side-effects”. Each recommendation is backed-up by a short paragraph summarising the evidence. The order of the recommendations partly follows the natural flow of treatment. And there are two tables (one with doses, the other one with side-effects) which are quoted several times. Click here to read more.

©2017 CINP | CINP is a registered Scottish Charity, no: SC042462